Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia.
Fiche publication
Date publication
avril 2018
Journal
Journal of internal medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr DECONINCK Eric
Tous les auteurs :
Craddock C, Versluis J, Labopin M, Socie G, Huynh A, Deconinck E, Volin L, Milpied N, Bourhis JH, Rambaldi A, Chevallier P, Blaise D, Manz M, Vellenga E, Vekemans MC, Maertens J, Passweg J, Vyas P, Schmid C, Löwenberg B, Ossenkoppele G, Mohty M, Cornelissen JJ, Nagler A,
Lien Pubmed
Résumé
Disease recurrence remains the major cause of death in adults with acute myeloid leukaemia (AML) treated using either intensive chemotherapy (IC) or allogenic stem cell transplantation (allo-SCT).
Mots clés
Acute myeloid leukaemia, intensive chemotherapy, kinetics, maintenance therapy, stem cell transplantation
Référence
J. Intern. Med.. 2018 Apr;283(4):371-379